Dunhill Financial’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Dunhill Financial's ADPT Position: Q3 2026 in Review
Dunhill Financial increased its Adaptive Biotechnologies (ADPT) stake by 2,800% in Q3 2026, buying an estimated $688 and bringing the position to 29 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #1682.
Dunhill Financial first reported a position in ADPT in Q4 2025 and has held it in 4 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Dunhill Financial held 29 shares of Adaptive Biotechnologies worth $43 as of Q3 2026.
- Dunhill Financial bought 28 Adaptive Biotechnologies shares in Q3 2026, an estimated $688.
- Adaptive Biotechnologies made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1682 holding.
- Dunhill Financial first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 4 quarters since.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.